CN1168484C - Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy - Google Patents
Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy Download PDFInfo
- Publication number
- CN1168484C CN1168484C CNB021340978A CN02134097A CN1168484C CN 1168484 C CN1168484 C CN 1168484C CN B021340978 A CNB021340978 A CN B021340978A CN 02134097 A CN02134097 A CN 02134097A CN 1168484 C CN1168484 C CN 1168484C
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- radix
- present
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 238000002512 chemotherapy Methods 0.000 title claims abstract description 12
- 201000002364 leukopenia Diseases 0.000 title claims abstract description 12
- 238000001959 radiotherapy Methods 0.000 title claims abstract description 12
- 231100001022 leukopenia Toxicity 0.000 title claims description 10
- 229940079593 drug Drugs 0.000 title description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 241000208340 Araliaceae Species 0.000 claims description 10
- 229940126678 chinese medicines Drugs 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 241001250596 Pleione Species 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000031023 Amana edulis Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000208365 Celastraceae Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000000336 Solanum dulcamara Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for curing leucopenia caused by cancer radiotherapy and chemotherapy. The present invention is made from Chinese traditional medicine of edible tulip, bittersweet herb, epimedium herb, lightyellow sophora root, angelica, rhizoma and ginseng, and is made into Chinese patent medicine capsules. The present invention has the functions of invigorating vital energy, nourishing blood, removing toxicity and removing stasis. The present invention has the advantages of good therapeutic effect, high effective speed, little curing expense, no toxic effect, no side effect and safe taking. The present invention is particularly suitable for curing leucopenia with vital energy deficiency and blood deficiency caused by cancer radiotherapy and chemotherapy.
Description
Technical field:
The present invention relates to a kind of medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes and preparation method thereof.
Background technology:
At present, the existing medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes generally all adopts Western medicine, though these Western medicine all have certain therapeutic effect, but ubiquity have certain toxic and side effects, medical expense height, the slow shortcoming that takes effect, so its result of use still is not ideal enough.
Summary of the invention:
The objective of the invention is: provide a kind of and have no side effect, good effect, take the medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes of comparison safety, to overcome the deficiency of existing medicine.
The present invention is achieved in that it makes the Chinese patent medicine of capsule shape by Pseudobulbus cremastrae seu pleiones, Herba Solani Lyrati, Herba Epimedii, Radix Sophorae Flavescentis, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, people's SHENQI flavor Chinese medicine, and each Chinese medicine component by weight is respectively: 25～900 parts of Pseudobulbus cremastrae seu pleiones, 25～700 parts of Herba Solani Lyratis, 25～600 parts of Herba Epimedii, 25～700 parts of Radix Sophorae Flavescentiss, 25～600 parts of Radix Angelicae Sinensis, 25～500 parts of the Rhizoma Atractylodis Macrocephalaes, 25～200 parts of Radix Ginsengs; When its seven flavors Chinese medicine is made the Chinese patent medicine of capsule shape, it is standby earlier Radix Angelicae Sinensis and Radix Ginseng two flavor Chinese medicines to be worn into fine powder, all the other Chinese medicines of respectively distinguishing the flavor of decoct with water 3 times, 2 hours for the first time, for the second time and each 1 hour for the third time, the decocting liquid that decocts gained for three times merged and filter filtrate, then this filtrate is concentrated into relative density 25 ℃ the time and is 1.25～1.30 thick paste, add standby fine powder,, promptly make finished product during it is incapsulated through mixing, drying with after being ground into fine powder.
Owing to adopted technique scheme, the present invention compares with the existing medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes, it is raw material that the present invention adopts Chinese herbal medicine fully, be Miao medicine formula, it has the function of benefiting qi and nourishing blood, detoxicating and resolving stagnation of pathogens, it not only has good effect, instant effect, advantage that medical expense is low, has no side effect, takes safe advantage but also have.The present invention is particularly suitable for treating the disease that leukopenia that carcinosis radiotherapy and chemotherapy causes belongs to QI and blood deficiency person.
The specific embodiment:
Embodiments of the invention 1: get Pseudobulbus cremastrae seu pleiones 25 grams, Herba Solani Lyrati 25 grams, Herba Epimedii 25 grams, Radix Sophorae Flavescentis 25 grams, Radix Angelicae Sinensis 25 grams, the Rhizoma Atractylodis Macrocephalae 25 grams, Radix Ginseng 25 grams seven flavor Chinese medicines, it is standby earlier Radix Angelicae Sinensis and Radix Ginseng two flavor Chinese medicines to be worn into fine powder, all the other Chinese medicines of respectively distinguishing the flavor of decoct with water 3 times, 2 hours for the first time, for the second time with each 1 hour for the third time, the decocting liquid that decocts gained for three times merged and filter filtrate, then this filtrate is concentrated into relative density 25 ℃ the time and is 1.25～1.30 thick paste, add standby fine powder, through mixing, dry and be ground into fine powder after, promptly make finished product during it is incapsulated by every 0.35 gram.
Embodiments of the invention 2: get Pseudobulbus cremastrae seu pleiones 450 grams, Herba Solani Lyrati 350 grams, Herba Epimedii 300 grams, Radix Sophorae Flavescentis 350 grams, Radix Angelicae Sinensis 300 grams, the Rhizoma Atractylodis Macrocephalae 250 grams, Radix Ginseng 100 grams seven flavor Chinese medicines, make the capsule shape finished product by the method for embodiment 1 then and get final product.
Embodiments of the invention 3: get Pseudobulbus cremastrae seu pleiones 900 grams, Herba Solani Lyrati 700 grams, Herba Epimedii 600 grams, Radix Sophorae Flavescentis 700 grams, Radix Angelicae Sinensis 600 grams, the Rhizoma Atractylodis Macrocephalae 500 grams, Radix Ginseng 200 grams seven flavor Chinese medicines, make the capsule shape finished product by the method for embodiment 1 then and get final product.
When taking above-mentioned finished medicines, oral, one time 3,3 times on the one.General one or two month is a course of treatment.
Claims (4)
1, a kind of medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes, it is characterized in that: it is the capsule made from the raw material of following consumption: Pseudobulbus cremastrae seu pleiones 25 grams, Herba Solani Lyrati 25 grams, Herba Epimedii 25 grams, Radix Sophorae Flavescentis 25 grams, Radix Angelicae Sinensis 25 grams, the Rhizoma Atractylodis Macrocephalae 25 grams, Radix Ginseng 25 grams.
2, a kind of medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes, it is characterized in that: it is the capsule made from the raw material of following consumption: Pseudobulbus cremastrae seu pleiones 450 grams, Herba Solani Lyrati 350 grams, Herba Epimedii 300 grams, Radix Sophorae Flavescentis 350 grams, Radix Angelicae Sinensis 300 grams, the Rhizoma Atractylodis Macrocephalae 250 grams, Radix Ginseng 100 grams.
3, a kind of medicine that is used for the treatment of the leukopenia that carcinosis radiotherapy and chemotherapy causes, it is characterized in that: it is the capsule made from the raw material of following consumption: Pseudobulbus cremastrae seu pleiones 900 grams, Herba Solani Lyrati 700 grams, Herba Epimedii 600 grams, Radix Sophorae Flavescentis 700 grams, Radix Angelicae Sinensis 600 grams, the Rhizoma Atractylodis Macrocephalae 500 grams, Radix Ginseng 200 grams.
4, a kind of preparation method as arbitrary described medicine in the claim 1 to 3, it is characterized in that: it is standby that it comprises the following steps: that earlier Radix Angelicae Sinensis and Radix Ginseng two flavor Chinese medicines are worn into fine powder, all the other Chinese medicines of respectively distinguishing the flavor of decoct with water 3 times, 2 hours for the first time, for the second time with each 1 hour for the third time, the decocting liquid that decocts gained for three times merged and filter filtrate, then this filtrate is concentrated into relative density 25 ℃ the time and is 1.25～1.30 thick paste, add standby fine powder, through mixing, drying with after being ground into fine powder, it is incapsulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021340978A CN1168484C (en) | 2002-11-15 | 2002-11-15 | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021340978A CN1168484C (en) | 2002-11-15 | 2002-11-15 | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1413695A CN1413695A (en) | 2003-04-30 |
| CN1168484C true CN1168484C (en) | 2004-09-29 |
Family
ID=4747559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021340978A Expired - Lifetime CN1168484C (en) | 2002-11-15 | 2002-11-15 | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1168484C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101491642B (en) * | 2005-09-29 | 2011-01-19 | 贵州百祥制药有限责任公司 | Medicine preparation for treating cancer and preparation method thereof |
| CN101491643B (en) * | 2005-09-29 | 2011-01-19 | 贵州百祥制药有限责任公司 | Medicine preparation for treating cancer and preparation method thereof |
-
2002
- 2002-11-15 CN CNB021340978A patent/CN1168484C/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101491642B (en) * | 2005-09-29 | 2011-01-19 | 贵州百祥制药有限责任公司 | Medicine preparation for treating cancer and preparation method thereof |
| CN101491643B (en) * | 2005-09-29 | 2011-01-19 | 贵州百祥制药有限责任公司 | Medicine preparation for treating cancer and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1413695A (en) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485830B (en) | Pure Chinese medicine anti-aging health-care capsule | |
| CN1167456C (en) | Compund paste of donkey-skin gelatin for enriching the blood | |
| CN106620609A (en) | Hair regeneration formula and preparation method for same | |
| CN108029821A (en) | Bark of eucommia solid health-care tea and preparation method thereof | |
| CN101623446A (en) | Chinese medicinal composition for treating alopecia and premature graying of hair | |
| CN102715509B (en) | Health care product with function of expelling noxious substances to keep young | |
| CN104621310A (en) | Health tea and application thereof | |
| CN104001022A (en) | Traditional Chinese medicine for treating pediatric hyperkinetic syndrome and preparation method thereof | |
| CN1168484C (en) | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy | |
| CN103735899B (en) | A kind of hypertension injection care drug and preparation method thereof | |
| CN1228063C (en) | Medicine for treating liver disease | |
| CN1105588A (en) | Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method | |
| CN101953986B (en) | Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency | |
| CN1060368C (en) | Traditional Chinese medicine Jinjiangkebao for treating cough | |
| CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
| CN101264164A (en) | Medicinal composition for treating tumor and preparation thereof | |
| CN1164316C (en) | Stilbene paste capsule of rising white blood cell for curing disease of leucopenia | |
| CN103520426B (en) | Traditional Chinese medicine for relieving gastrointestinal side effects caused by acquired immune deficiency syndrome antiviral drug | |
| CN101856448A (en) | Chinese medicament for treating diabetes mellitus | |
| CN104997939A (en) | Pharmaceutical composition for treating endocrine dyscrasia, and preparation method thereof | |
| CN1052914C (en) | Suyuwan pill for curing leucoderma | |
| CN104606484A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency and preparation method thereof | |
| CN104547425A (en) | Decoction medicine for treating paralytic strabismus and preparation method pf decoction medicine | |
| CN1259363A (en) | Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: GUIZHOU BAIXIANG PHARMACEUTICAL CO. Free format text: FORMER NAME OR ADDRESS: GUIZHOU QIKAI PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee after: Guizhou Baixiang Pharmaceutical Co.,Ltd. Address before: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee before: GUIZHOU QIKAI PHARMACEUTICAL Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20081224 Pledge (preservation): Pledge |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100127 Pledge (preservation): Pledge registration |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20100127 Pledge (preservation): Pledge |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20110523 Granted publication date: 20040929 Pledgee: Guiyang City Commercial Bank Hing Building Branch Pledgor: Guizhou Baixiang Pharmaceutical Co.,Ltd. Registration number: 2010520000687 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: 550002, No. 5 Yinhua Road, Nanming District, Guizhou, Guiyang Patentee after: GUIZHOU YIBAI WOMAN BIG PHARMACEUTICAL FACTORY Address before: 550001, A-12 building, Zhicheng building, 1 East Yanan Road, Guiyang, Guizhou Patentee before: Guizhou Baixiang Pharmaceutical Co.,Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040929 |